Skip to main content
. 2021 Feb 9;12(5):813–824. doi: 10.1021/acschemneuro.0c00788

Table 4. Neural Damage in Patients Affected by COVID-19a.

study case age gender chemosensory symptoms imaging findings
Conde et al.65   79     massive intracerebral bleeding from the right hemisphere
Filatov et al.66 1 encephalopathy 74     no acute abnormalities
k82 1 Miller Fisher syndrome 50 M anosmia; ageusia  
  1 polyneuritis cranialis 39 M    
Jebril83 cited: Desforges et al.60 and Filatov et el.66
Moriguchi et al.84 1 meningitis/encephalitis 24 M   CT: no evidence of brain edema; 15 days later DWI: hyperintensity along the wall of inferior horn of right lateral ventricle; FLAIR: hyperintense signal changes in the right mesial temporal lobe and hippocampus with slight hippocampal atrophy; contrast-enhanced imaging showed no definite dural enhancement
Poyiadji et al.68 1 acute hemorrhagic necrotizing encephalopathy >45 F   noncontrast CT: symmetric hypoattenuation within the bilateral medial thalami with a normal CT angiogram and CT venogram; MRI: hemorrhagic rim enhancing lesions within the bilateral thalami, medial temporal lobes, and subinsular regions
Sharifi-Razavi et al.85 1 intracerebral hemorrhage 79 M   CT: massive intracerebral hemorrhage in right hemisphere accompanied by intraventricular and subarachnoid hemorrhage
Zayet et al.54 1 acute encephalopathy        
Zhao et al.86 1 Guillain-Barré syndrome 61 F    
Zhou et al.67 1 viral encephalitis 56      
a

CT, computed tomographic images; DWI, diffusion weighted images; F, female; FLAIR, fluid-attenuated inversion recovery images; M, male; MRI, magnetic resonance imaging.